FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency [Yahoo! Finance]
FSD Pharma Inc. - Class B Subordinate Voting Shares (HUGE)
Company Research
Source: Yahoo! Finance
biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced that on April 5, 2024 it received a written notification (the " Notification Letter ") from the Nasdaq Stock Market LLC (" Nasdaq ") that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq's rules for continued listing on the Nasdaq Capital Market. The Notification Letter is only a notification of deficiency and not a notice of delisting. As such, the Notification Letter has no effect on the listing or trading of the Company's Class B Subordinate Voting Shares (" Class B Shares ") on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires securities listed on the Nasdaq Capital Market to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period
Show less
Read more
Impact Snapshot
Event Time:
HUGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUGE alerts
High impacting FSD Pharma Inc. - Class B Subordinate Voting Shares news events
Weekly update
A roundup of the hottest topics
HUGE
News
- FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol IntoxicationAccesswire
- FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)Accesswire
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]Yahoo! Finance
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)Accesswire
- FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products [Yahoo! Finance]Yahoo! Finance
HUGE
Sec Filings
- 4/30/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/22/24 - Form 6-K
- HUGE's page on the SEC website